Role of the QuantiFERON®-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis

SETTING: Tertiary care hospitals in India.

OBJECTIVE: To compare the performance of the QuantiFERON®-TB Gold In-Tube test (QFT-GIT) with that of the tuberculin skin test (TST) in the diagnosis of intrathoracic childhood tuberculosis (TB).

METHODS: Children with intrathoracic TB were enrolled in a randomised controlled trial studying micronutrient supplementation in intrathoracic TB. They underwent TST and QFT-GIT before starting daily anti-tuberculosis treatment.

RESULTS: Of 362 children (median age 115.5 months, IQR 73-144, 55% girls) enrolled in the study, microbiological confirmation of TB was obtained in 128 (35%). The TST was positive in 337 (93%, 95%CI 90-95.5) and QFT-GIT in 297 (82%, 95%CI 77.8-85.6). Sensitivity of TST and QFT-GIT in culture-confirmed TB cases was respectively 90.5% (95%CI 84.1-94.5) and 82.6% (95%CI 74.9-88.4). QFT-GIT positivity rate correlated with TST induration (P < 0.001). TST was influenced by the disease spectrum (P = 0.004) and the age of the children (P = 0.002); QFT-GIT remained unaffected by these factors. Bacille Calmette-Guérin immunisation status, weight-for-age Z-scores and microbiological confirmation of Mycobacterium tuberculosis did not influence the performance of either test.

CONCLUSION: In high-burden countries, QFT-GIT is comparable to TST and offers no added advantage in the diagnosis of childhood intrathoracic TB.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease - 17(2013), 11 vom: 05. Nov., Seite 1383-8

Sprache:

Englisch

Beteiligte Personen:

Lodha, R [VerfasserIn]
Mukherjee, A [VerfasserIn]
Saini, D [VerfasserIn]
Saini, S [VerfasserIn]
Singh, V [VerfasserIn]
Singh, S [VerfasserIn]
Grewal, H M S [VerfasserIn]
Kabra, S K [VerfasserIn]
Delhi TB Study Group [VerfasserIn]
Arya, T [Sonstige Person]
Bhatnagar, S [Sonstige Person]
Chandra, J [Sonstige Person]
Dutta, A K [Sonstige Person]
Doherty, T M [Sonstige Person]
Friis, H [Sonstige Person]
Grewal, H M S [Sonstige Person]
Hesseling, A C [Sonstige Person]
Kabra, S K [Sonstige Person]
Lodha, R [Sonstige Person]
Marais, B [Sonstige Person]
Mukherjee, A [Sonstige Person]
Parashar, D [Sonstige Person]
Prajapati, S [Sonstige Person]
Purohit, K [Sonstige Person]
Saini, D [Sonstige Person]
Saini, S [Sonstige Person]
Singh, R R [Sonstige Person]
Singh, S [Sonstige Person]
Singh, V [Sonstige Person]

Links:

Volltext

Themen:

Antitubercular Agents
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 30.05.2014

Date Revised 15.10.2013

published: Print

Citation Status MEDLINE

doi:

10.5588/ijtld.13.0348

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM231697430